Quantcast

Latest Overactive bladder Stories

2014-09-10 08:29:51

MINNEAPOLIS, Sept. 10, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 5(th) Annual Craig-Hallum Alpha Select Conference on Thursday, September 18. Brett Reynolds, SVP and CFO, and Darin Hammers, SVP of Global Sales and Marketing, will present at 12:00pm ET and meet with investors one on one at...

2014-08-19 08:30:23

IRVINE, Calif., Aug. 19, 2014 /PRNewswire/ -- Nearly half (46 percent) of women age 45 or older who experience symptoms of overactive bladder (OAB) say their current treatment does not address their OAB symptoms, according to a recent survey (n=1,017) conducted by The Harris Poll on behalf of Allergan, Inc.(1) An estimated 39 million Americans are currently living with OAB,(2) a common, sometimes disabling condition(3) often associated with a considerable impact on patients with symptoms...

2014-08-11 16:28:13

MINNEAPOLIS, Aug. 11, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services (NGS) has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for...

2014-08-06 08:30:46

MINNEAPOLIS, Aug. 6, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13. Rob Kill, President and CEO, will present at 5:00pm ET and meet with investors one on one at the conference at the Intercontinental Hotel Boston....

2014-07-10 08:27:22

MINNEAPOLIS, July 10, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the first quarter ended June 30, 2014 after the market close on Thursday, July 24, 2014. The Company will host a conference call and webcast to discuss these results on Thursday, July 24, 2014 at 4:30 p.m. Eastern Time (3:30 p.m. Central...

2014-06-30 08:29:46

MINNEAPOLIS, June 30, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, reported that in the recently updated Overactive Bladder (OAB) treatment guideline from the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), Percutaneous Tibial Nerve Stimulation (PTNS) is...

2014-06-16 08:27:52

MINNEAPOLIS, June 16, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24. Rob Kill, President and CEO, will present at 1:00pm ET and meet with investors one on one at the conference at The Westin New York Grand Central. Attendance...

2014-06-02 08:29:20

~Roche Brings Deep Healthcare Industry and Business Strategy Experience MINNEAPOLIS, June 2, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Kevin H. Roche has been appointed to the Company's Board of Directors effective May 29, 2014. Mr. Roche will chair the Nominating Committee and also serve as a member of Uroplasty's...

2014-05-20 16:26:15

National Consumer Contest Will Award One Woman $10,000 to Help Realize Her Dream of Reinvention WHITEHOUSE STATION, N.J., May 20, 2014 /PRNewswire/ -- Merck Consumer Care, the makers of OXYTROL FOR WOMEN - the first and only over-the-counter treatment for overactive bladder (OAB) - and MORE magazine announced today findings from a survey of 1,857 women 50 and over on MORE's reader panel revealing that in a perfect world 97% of them would choose a variety of ways to reinvent...

urine not sterile
2014-05-19 08:55:27

Brett Smith for redOrbit.com - Your Universe Online Although urine has long-been thought to be sterile, a new study has found that not only can bacteria survive in urine – they are relatively prolific in women with overactive bladder (OAB). "Doctors have been trained to believe that urine is germ-free," said Linda Brubaker, dean of Loyola University Chicago’s Stritch School of Medicine (SSOM) and an investigator in the new study, which was presented on Sunday as part of the 2014...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related